Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJJPA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,564
Award facts
- Contract value 100% obligated
- $6,564.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors, with a contract ceiling value of $6,564.18. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a scheduled completion date of August 14, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical prime vendor agreement running through December 2026.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies supporting Defense Health Agency operations and other government healthcare systems. The Dupixent supply under this delivery order supports the military healthcare enterprise's pharmaceutical needs, with Dupixent being a specialty biologic medication used for treating eczema, asthma, and other inflammatory conditions. The contract reflects AmerisourceBergen's ongoing role as a preferred supplier for federal medical procurement through its competitive performance on the DLA prime vendor vehicle.
Quick answers
Who was awarded contract SPE2DB25FJJPA?
SPE2DB25FJJPA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FJJPA worth?
The government has obligated $6,564 on SPE2DB25FJJPA.
Is contract SPE2DB25FJJPA an order under another contract?
Yes. SPE2DB25FJJPA is a delivery order under SPE2DB24D2102, an indefinite delivery contract.
Was contract SPE2DB25FJJPA competed?
The extent of competition for SPE2DB25FJJPA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award